James L. Cunniff, who serves as both Chief Executive Officer and President of Electromed, Inc. (NASDAQ:ELMD), completed a transaction involving the sale of 9,700 shares of the company's common stock on June 8, 2026. The aggregate value of this disposition reached $354,095. The shares were divested at weighted average prices that fluctuated between $36.249 and $37.7729 per share. This sale activity directly followed Cunniff's acquisition of an identical quantity of 9,700 shares through the exercise of employee stock options, which were purchased at a fixed price of $17.25 per share, resulting in a total exercise cost of $167,325.
The specific mechanics of the sale involved multiple tranches. The transaction included 7,003 shares sold at a weighted average price of $36.249, 1,671 shares sold at a weighted average price of $36.79750, and an additional 1,026 shares sold at a weighted average price of $37.7729. The options that Cunniff exercised were part of a broader employee stock option grant. These specific options are structured to vest and become exercisable in three equal annual installments. The vesting schedule is set for the first business days of September in 2025, 2026, and 2027. The options carry an expiration date of September 3, 2034. Post-transaction, Cunniff's direct holdings in Electromed common stock stand at 147,751 shares. Furthermore, he retains an additional 19,400 unexercised employee stock options.
The timing of this insider sale coincides with a period of significant market movement for Electromed. The company's shares have generated an 87% return over the trailing twelve-month period. However, valuation analysis indicates that the stock is currently trading above its calculated Fair Value. Despite this premium valuation, the company maintains a low P/E ratio when measured against near-term earnings growth projections. The Price/Earnings-to-Growth ratio, or PEG ratio, stands at 0.63. Investors seeking deeper valuation insights can access 12 additional ProTips and comprehensive analysis through the detailed Pro Research Report available for ELMD.
Financial performance metrics for Electromed support the recent market activity. The company reported earnings for the third quarter of fiscal year 2026 that surpassed analyst consensus estimates. The reported earnings per share (EPS) came in at $0.35, significantly outperforming the projected $0.24. This discrepancy represents an earnings surprise of 45.83%. Revenue for the quarter also exceeded expectations, reaching $18.6 million against an anticipated $17.82 million. These financial results have drawn attention from investors and analysts, highlighting the company's robust operational performance during this specific period.
Current market data shows ELMD trading at $36.29, reflecting a decline of $0.79 or 2.13% from the previous close. The stock is closed at this price as of 15:59:59 USD. After-hours trading at 17:29:56 shows no change, with the price remaining at $36.29. The stock's performance over various timeframes, including one day, one week, one month, six months, one year, five years, and maximum history, is tracked through analytical tools. The company is included in AI-picked strategies, and investors are encouraged to review these strategies to assess if ELMD represents a bargain. A Fair Value calculator utilizing 17 proven industry valuation models is available to determine the stock's intrinsic value and identify potential upside opportunities.